Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
How is that different from like antidepressants or thyroid medication, etc? You’ll have symptoms again if you stop the pills.
The difference is the social understanding.
Nobody gets thyroid-shamed. People understand hyper-/hypo-thyroidism as an objective symptom of a physiological problem.
Obesity is not viewed the same, though it really should be.
Did I say anything about other medication?
No?
Why bring it up?
“These other things aren’t a permanent cure either!” Is a lazy response.
The original comment was acting like gold-1s are a cure where traditional weight loss isn’t. The reality is if you go off them, the same thing happens as going off your diet.
They’re a cure for having an uncontrollable appetite, which makes dieting difficult to impossible.
So if you stop taking them, you retain your controlled appetite?
Spoiler: nope.
They’re not a cure for anything.
That’s so pedantic, but yes, they’re a treatment for an uncontrollable appetite. Do you mean to suggest that you’re against medical treatments which are not cures?